Skip to main content

CVS HEALTH Corp statistics

  • CVS · NYSE
  • Retail
  • Health Care Services
  • S&P 500
$89.35−0.49%Close 13 Nov 2026 · Market value $113.1B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

CVS HEALTH Corp is valued at $113.1B on its latest close. Its price is 10.3 times its earnings.

Market value$113.1B
Enterprise value$175.0B
Price / earnings10.25
Price / sales0.27
Price / book1.41
EV / EBITDA8.94
EV / sales0.42
Price / free cash flow7.27
Price / free cash flow, own 5-year average11.97
EV / EBIT11.52
EV / free cash flow11.15
Free cash flow yield13.8%
Dividend yield3.0%

Share price

Latest close$89.35
Day's change−0.5%
52-week high$110.68
52-week low$69.51
From 52-week high−19.3%
Return · 1 month−3.3%
Return · 3 months−4.6%
Return · year to date+12.6%
Return · 1 year+11.3%
Beta · 1 year against the S&P 500−0.02
50-day average$89.66
200-day average$89.17
RSI 1450.9
Average volume · 20 sessions11.0M

Margins and returns

For fiscal 2025, as filed.

Operating margin1.2%
Net margin0.4%
Free cash flow margin1.9%
Return on equity2.3%
Return on assets1.5%
Return on invested capital2.2%
Return on invested capital, 5-year average4.2%
Return on capital employed2.8%
Stock-based compensation / revenue0.1%

Financial position

At the end of fiscal 2025.

Cash and equivalents$8.45B
Total debt$79.95B
Net debt$69.35B
Current ratio0.84
Quick ratio0.61
Debt / equity1.06
Net debt / EBITDA7.48
Interest coverage1.49

Growth

Revenue, latest quarter on a year+5.4%
Revenue, twelve months on a year+6.7%
EPS, twelve months on a year+2218%
Revenue, 5-year compound+8.4%
Revenue, 10-year compound+10.1%
Net income, 5-year compound−24.4%
Free cash flow, 5-year compound−10.3%
EPS, 5-year compound−23.9%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares1.3B
Shares outstanding, 5-year compound−0.7%
Net share repurchases−$394.0M
Dividends per share$2.66
Dividend payout192%

Taxes

For fiscal 2025, as filed.

Income tax expense$408.0M
Effective tax rate19.1%

CVS in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.